Jenna Sopfe, MD
Assistant Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation
Medical School:
- MD, Vanderbilt University School of Medicine (2012)
- MSCS, University of Colorado Denver (2018)
- BS, University of California–Los Angeles (CA) (2008)
- University of Colorado (Children's Hospital Colorado) Program, Pediatrics (2015)
- University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology (2018)
Professional Titles
- Assistant Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation
- Assistant Professor of Pediatrics
Research Interests
My research interests are in pediatric oncology outcomes, late effects, and patient quality of life.
Publications
- Macaruso N, Campbell K, Cost C, Sopfe J. Provider Documentation of Tinnitus in Childhood Cancer Survivors. J Pediatr Hematol Oncol. 2020 Oct 15. [Epub ahead of print] PubMed PMID: 33065711
- Sopfe J, Greffe B, Treece AL. Metastatic NUT Midline Carcinoma Treated With Aggressive Neoadjuvant Chemotherapy, Radiation, and Resection: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2020 Jun 16. [Epub ahead of print] PubMed PMID: 32555032
- Sopfe J, Gupta A, Appiah LC, Chow EJ, Peterson PN. Sexual Dysfunction in Adolescent and Young Adult Survivors of Childhood Cancer: Presentation, Risk Factors, and Evaluation of an Underdiagnosed Late Effect: A Narrative Review. J Adolesc Young Adult Oncol. 2020 Oct;9(5):549-560. PubMed PMID: 32380878
- Sopfe J, Vigers T, Pyle L, Giller RH, Forlenza GP. Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation. Diabetes Technol Ther. 2020 Oct;22(10):727-733. PubMed PMID: 32105513
- Grimes A, Mohamed A, Sopfe J, Hill R, Lynch J. Hyperglycemia During Childhood Cancer Therapy: Incidence, Implications, and Impact on Outcomes. J Natl Cancer Inst Monogr. 2019 Sep 1;2019(54):132-138. PubMed PMID: 31532529
- Phillips CA, Razzaghi H, Aglio T, McNeil MJ, Salvesen-Quinn M, Sopfe J, Wilkes JJ, Forrest CB, Bailey LC. Development and evaluation of a computable phenotype to identify pediatric patients with leukemia and lymphoma treated with chemotherapy using electronic health record data. Pediatr Blood Cancer. 2019 Sep;66(9):e27876. PubMed PMID: 31207054
- Sopfe J, Pyle L, Keating AK, Campbell K, Liu AK, Wadwa RP, Verneris MR, Giller RH, Forlenza GP. Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients. Blood Adv. 2019 Feb 12;3(3):350-359. PubMed PMID: 30718242
- Sopfe J, Endres A, Campbell K, Hayes K, Trout AT, Liang X, Lorsbach R, O'Brien MM, Cost CR. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study. Pediatr Blood Cancer. 2019 May;66(5):e27613. PubMed PMID: 30680887
- Grimes A, Mohamed A, Sopfe J, Hill R, Lynch J. Hyperglycemia During Childhood Cancer Therapy: Incidence, Implications, and Impact on Outcomes. J Natl Cancer Inst Monogr. 2019 Sep 1;2019(54):132-138. PubMed PMID: 31532529
- Phillips CA, Razzaghi H, Aglio T, McNeil MJ, Salvesen-Quinn M, Sopfe J, Wilkes JJ, Forrest CB, Bailey LC. Development and evaluation of a computable phenotype to identify pediatric patients with leukemia and lymphoma treated with chemotherapy using electronic health record data. Pediatr Blood Cancer. 2019 Sep;66(9):e27876. PubMed PMID: 31207054
- Faulk KE, Sopfe JM, Campbell K, Liptzin DR, Liu AK, Franklin ARK, Cost CR. Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin. Br J Haematol. 2018 Sep 10. [Epub ahead of print] PubMed PMID: 30198571
- Zastoupil L, McIntosh A, Sopfe J, Burrows J, Kraynik J, Lane L, Hanson J, Seltz LB. Positive Impact of Transition From Noon Conference to Academic Half Day in a Pediatric Residency Program. Acad Pediatr. 2017 May - Jun;17(4):436-442. PubMed PMID: 28130128
- Esbenshade AJ, Sopfe J, Zhao Z, Li Z, Campbell K, Simmons JH, Friedman DL. Screening for vitamin D insufficiency in pediatric cancer survivors. Pediatr Blood Cancer. 2014 Apr;61(4):723-8. PubMed PMID: 24194420
- Sopfe J, Simmons JH. Failure to thrive, hyponatremia, and hyperkalemia in a neonate. Pediatr Ann. 2013 May;42(5):74-9. PubMed PMID: 23641881
- Smith HA, Boyd J, Fuchs DC, Melvin K, Berry P, Shintani A, Eden SK, Terrell MK, Boswell T, Wolfram K, Sopfe J, Barr FE, Pandharipande PP, Ely EW. Diagnosing delirium in critically ill children: Validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit. Crit Care Med. 2011 Jan;39(1):150-7. PubMed PMID: 20959783
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
Hospital Affiliation
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
Hospital Affiliation
- Children's Hospital Colorado
Specialty Information
Specialties
- Pediatric Hematology / Oncology, Board Certification
Clinical Interests
My focus is on taking care of children, adolescents and young adults with pediatric solid tumors of all types, as well as caring for survivors of pediatric cancers.
Care Philosophy
The privilege of being a part of a patient’s and family’s lives at such a difficult time is something that I take very seriously. While my ultimate goal as an oncologist is to cure my patients of their cancers, I strongly believe in the importance of considering each child and family's whole experience through this difficult journey. It is our duty to work toward reducing harmful side effects both during and after treatment and I strive to consider these short and long term effects at every interaction.
My focus is on taking care of children, adolescents and young adults with pediatric solid tumors of all types, as well as caring for survivors of pediatric cancers.
Care Philosophy
The privilege of being a part of a patient’s and family’s lives at such a difficult time is something that I take very seriously. While my ultimate goal as an oncologist is to cure my patients of their cancers, I strongly believe in the importance of considering each child and family's whole experience through this difficult journey. It is our duty to work toward reducing harmful side effects both during and after treatment and I strive to consider these short and long term effects at every interaction.
General Information
Medical Schools:
- MD, Vanderbilt University School of Medicine (2012)
Graduate Schools:
- MSCS, University of Colorado Denver (2018)
Undergraduate Schools:
- BS, University of California–Los Angeles (CA) (2008)
Residency Programs:
- University of Colorado (Children's Hospital Colorado) Program, Pediatrics (2015)
Fellowships:
- University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology (2018)